Looking to Partner with the World CNS Series?
Following a year of significant pharma acquisitions, approvals of transformative first-in-class drugs, and a surge in financial backing to bolster innovation across new targets and preclinical pipelines, 2026 is set to continue this momentum, with more companies prioritising neuroscience drug development than ever before.
If you offer relevant capabilities in this space and would like to align your brand with the CNS community, contact us to promote your expertise through a bespoke commercial partnership package.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.
Download Your Copy of the Sponsorship Prospectus
Explore the Brand-New Agenda
Hear fresh industry perspectives, strategic case studies, and candid discussions tackling the biggest scientific and commercial questions shaping COPD R&D today.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the forefront of this resurging market.
Join An Intimate Community of Experts
Join a highly selective group of experts across discovery, translational, clinical, and regulatory development to exchange insights and build meaningful, high‑impact connections.